This activity is supported by educational grants from

Amgen, Inc. Celgene Corporation Cephalon Oncology Eisai Inc. Lilly USA, LLC Genentech BioOncology / Biogen Idec Genzyme Corporation Millennium Pharmaceuticals, Inc. Novartis sanofi-aventis Group
 
  Click here for a downloadable PDF agenda  
  7:30 AM Registration and Breakfast
  8:00 AM

Welcome and Opening Remarks
Ruemu E. Birhiray, MD - Chair and Michael C. Wiemann, MD – Co-Chair

  
  8:15 AM

Disorders of Platelets, Neutrophils, and RBC
Craig M. Kessler, MD

  
  8:40 AM

Myeloproliferative Disorders
Ayalew Tefferi, MD

  
  9:05 AM

Multiple Myeloma
Kenneth C. Anderson, MD

  
  9:30 AM

Panel Discussion

  
  9:50 AM

Break

  
  10:05 AM T. Howard Lee Keynote Lecture, Aggressive Lymphomas
James O. Armitage, MD		  
  10:50 AM

Indolent Non-Hodgkin Lymphoma
David G. Maloney, MD, PhD

  
  11:15 AM

Progress in Vaccine and Immunotherapy of Vaccines
Larry W. Kwak, MD, PhD

  
  11:40 AM

Panel Discussion

  
  12:00 PM

Lunch

  
  12:45 PM

Acute Lymphocytic Leukemia
Richard M. Stone, MD

  
  1:10 PM Acute Myelogenous Leukemia
Martin S. Tallman, MD		  
  1:35 PM

Chronic Lymphocytic Leukemia
Neil E. Kay, MD

  
  2:00 PM

Chronic Myelogenous Leukemia
Richard A. Larson, MD

  
  2:25 PM

Break

  
  2:45 PM Stem Cell Transplantation
Richard W. Childs, MD, CMDR, USPHS		  
  3:10 PM    Panel Discussion – Challenging Cases in Leukemia  
  3:50 PM Concluding Remarks  
  4:00 PM Adjourn  

 

 Program subject to change